Menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantation
ObjectivesTo assess the severity of menopausal symptoms and the correlation among different quality of life questionnaires and compare the quality of life of patients who underwent hematopoietic stem cell transplantation (HSCT) for hematological disorders with the norm group in order to facilitate p...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-02-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1050959/full |
| _version_ | 1797893697040285696 |
|---|---|
| author | Huina Su Huiling Li Hua Zhang Xin Yang Chaohua Wang |
| author_facet | Huina Su Huiling Li Hua Zhang Xin Yang Chaohua Wang |
| author_sort | Huina Su |
| collection | DOAJ |
| description | ObjectivesTo assess the severity of menopausal symptoms and the correlation among different quality of life questionnaires and compare the quality of life of patients who underwent hematopoietic stem cell transplantation (HSCT) for hematological disorders with the norm group in order to facilitate personalized and directed therapeutic intervention for patients.MethodsWe recruited women who had premature ovarian failure (POF) after HSCT for hematologic diseases in the gynecological endocrinology outpatient clinic of Peking University People's Hospital. Women with HSCT were included in the study if they had 6 months of spontaneous amenorrhea with serum follicle-stimulating hormone levels greater than 40 mIU/mL taken 4 weeks apart. The patients who had other causes of POF were excluded. During the survey, all women were required to fill out the questionnaires [Quality of Life Questionnaire (MENQOL), Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and 36-item Short-Form (SF-36)] online. We analyzed the severity of menopausal symptoms, anxiety, and depression in Participants. In addition, differences on the SF-36 scale scores between the study group and norm groups were examined.ResultsIn total, 227 (93.41%) patients completed the survey and were analyzed. The severity of all symptoms is “none and mild” in MRS, MENQOL, GAD-7, and PHQ-9. On the MRS, the most common symptoms were irritability, physical and mental exhaustion, and sleep problems. The severest symptoms were sexual problems (53, 73.82%), followed by sleep problems (44, 19.38%) and mental and physical exhaustion (39, 17.18%). In the MENQOL, the most common symptoms were psychosocial and physical symptoms. The severest symptoms were sexual symptoms (35, 48.75%) followed by psychosocial symptoms (23, 10.13%). Moderate-severe scores were shown in 11.89% (27) and 18.72% (42) cases in the GAD-7 and PHQ-9, respectively. Based on SF-36, in comparison with the norm group, the HSCT participants had higher vitality scores and lower role physical, physical functioning, and role emotional scores aged 18–45. In addition, the HSCT participants had lower mental health scores aged 18–25, and lower general health scores aged 25–45. No strong correlation was observed between questionnaires in our study.ConclusionOverall, menopausal symptoms are milder in female patients after HSCT. There is no single scale that comprehensively assesses the patient's quality of life after HSCT. We need to assess the severity of various symptoms in patients using different scales. |
| first_indexed | 2024-04-10T06:57:00Z |
| format | Article |
| id | doaj.art-4a214a92583c4500b7bfee6af7f54f9a |
| institution | Directory Open Access Journal |
| issn | 1664-0640 |
| language | English |
| last_indexed | 2024-04-10T06:57:00Z |
| publishDate | 2023-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Psychiatry |
| spelling | doaj.art-4a214a92583c4500b7bfee6af7f54f9a2023-02-28T06:57:03ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402023-02-011410.3389/fpsyt.2023.10509591050959Menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantationHuina Su0Huiling Li1Hua Zhang2Xin Yang3Chaohua Wang4Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, ChinaClinical Epidemiology Research Center, Peking University Third Hospital, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, ChinaDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, ChinaObjectivesTo assess the severity of menopausal symptoms and the correlation among different quality of life questionnaires and compare the quality of life of patients who underwent hematopoietic stem cell transplantation (HSCT) for hematological disorders with the norm group in order to facilitate personalized and directed therapeutic intervention for patients.MethodsWe recruited women who had premature ovarian failure (POF) after HSCT for hematologic diseases in the gynecological endocrinology outpatient clinic of Peking University People's Hospital. Women with HSCT were included in the study if they had 6 months of spontaneous amenorrhea with serum follicle-stimulating hormone levels greater than 40 mIU/mL taken 4 weeks apart. The patients who had other causes of POF were excluded. During the survey, all women were required to fill out the questionnaires [Quality of Life Questionnaire (MENQOL), Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and 36-item Short-Form (SF-36)] online. We analyzed the severity of menopausal symptoms, anxiety, and depression in Participants. In addition, differences on the SF-36 scale scores between the study group and norm groups were examined.ResultsIn total, 227 (93.41%) patients completed the survey and were analyzed. The severity of all symptoms is “none and mild” in MRS, MENQOL, GAD-7, and PHQ-9. On the MRS, the most common symptoms were irritability, physical and mental exhaustion, and sleep problems. The severest symptoms were sexual problems (53, 73.82%), followed by sleep problems (44, 19.38%) and mental and physical exhaustion (39, 17.18%). In the MENQOL, the most common symptoms were psychosocial and physical symptoms. The severest symptoms were sexual symptoms (35, 48.75%) followed by psychosocial symptoms (23, 10.13%). Moderate-severe scores were shown in 11.89% (27) and 18.72% (42) cases in the GAD-7 and PHQ-9, respectively. Based on SF-36, in comparison with the norm group, the HSCT participants had higher vitality scores and lower role physical, physical functioning, and role emotional scores aged 18–45. In addition, the HSCT participants had lower mental health scores aged 18–25, and lower general health scores aged 25–45. No strong correlation was observed between questionnaires in our study.ConclusionOverall, menopausal symptoms are milder in female patients after HSCT. There is no single scale that comprehensively assesses the patient's quality of life after HSCT. We need to assess the severity of various symptoms in patients using different scales.https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1050959/fullhematopoietic stem cell transplantationmenopausal symptomsquality of lifefemale survivorsSF-36 |
| spellingShingle | Huina Su Huiling Li Hua Zhang Xin Yang Chaohua Wang Menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantation Frontiers in Psychiatry hematopoietic stem cell transplantation menopausal symptoms quality of life female survivors SF-36 |
| title | Menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantation |
| title_full | Menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantation |
| title_fullStr | Menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantation |
| title_full_unstemmed | Menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantation |
| title_short | Menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantation |
| title_sort | menopausal symptoms and quality of life in female survivors treated with hematopoietic stem cell transplantation |
| topic | hematopoietic stem cell transplantation menopausal symptoms quality of life female survivors SF-36 |
| url | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1050959/full |
| work_keys_str_mv | AT huinasu menopausalsymptomsandqualityoflifeinfemalesurvivorstreatedwithhematopoieticstemcelltransplantation AT huilingli menopausalsymptomsandqualityoflifeinfemalesurvivorstreatedwithhematopoieticstemcelltransplantation AT huazhang menopausalsymptomsandqualityoflifeinfemalesurvivorstreatedwithhematopoieticstemcelltransplantation AT xinyang menopausalsymptomsandqualityoflifeinfemalesurvivorstreatedwithhematopoieticstemcelltransplantation AT chaohuawang menopausalsymptomsandqualityoflifeinfemalesurvivorstreatedwithhematopoieticstemcelltransplantation |